The vision to change the world
Life–changing therapy by global leaders in ophthalmology
Eyerising International is an Australian MedTech company developing life-impacting eye-health therapy to slow the progression of myopia. We are led by a team of world-renowned ophthalmology academics, researchers and a board with a proven track record in MedTech innovation, implementation, and clinical facilitation.
Patented childhood myopia control therapy
Eyerising International’s Myopia Management Repeated Low-Level Red–Light (RLRL) therapy was conceived and developed by ERI’s Chief Medical Officer, Professor Mingguang He, a global leader in myopia control and the development of artificial intelligence systems in ophthalmology. This innovation in childhood myopia control meets the quality, safety, and efficacy standards required by medical regulators in over 30 countries across Europe and Australasia.
Jason Sun
Founder, MD
Globally connected MedTech entrepreneur and healthcare / business executive 20+ years of health experience at a senior level Secured >10 regulatory approvals Raised >$20m AUD with successful exits Co-founder of two MedTech companies.
Michael Woods
Executive Director
Specialist investor and adviser in medical technology commercialization Non-executive director of Optain Health Inc Prior senior roles at Macquarie Group, Equis Funds Group.
Manny Pascual
Head of Commercial
Over 20 years of experience in the medical device industry Previous Marketing Director for CooperVision Asia Pacific Previous success in medical device company business expansion and acceleration.